  The cell cycle is tightly regulated by cyclins and their catalytic moieties,
the cyclin-dependent kinases (CDKs). Cyclin D1, in association with CDK4/6,
acts as a mitogenic sensor and integrates extracellular mitogenic signals and
cell cycle progression. When deregulated (overexpressed, accumulated,
inappropriately located), cyclin D1 becomes an oncogene and is recognized as a
driver of solid tumors and hemopathies. Recent studies on the oncogenic roles
of cyclin D1 reported non-canonical functions dependent on the partners of
cyclin D1 and its location within tumor cells or tissues. Support for these new
functions was provided by various mouse models of oncogenesis. Finally,
proteomic and transcriptomic data identified complex cyclin D1 networks. This
review focuses on these aspects of cyclin D1 pathophysiology, which may be
crucial for targeted therapy.
